Patient P-02333
Synthetic patientMETA-24 · Day 116 · 35–44 · F · baseline S20Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Favorable
Nutritional resilience
Declining
Discontinuation risk
23%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S20
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- Nutritional resilience-7
- Treatment adherence-3
- GI instability+2
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable55 min
stable · -1.9 vs previous 14 d
Sleep duration
Wearable7.3 h
stable · -0.0 vs previous 14 d
Energy level
Daily log6.2/10
stable · -0.2 vs previous 14 d
Steps
Wearable6,842
stable · +104 vs previous 14 d
GI burden
Companion25.3/100
worsening · +4.9 vs previous 14 d
Adherence
Companion85.5 %
stable · +1.2 vs previous 14 d
Sleep quality
Wearable51.8/100
worsening · -2.1 vs previous 14 d
Glucose, CGM daily mean
CGM127 mg/dL
stable · +4.0 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading drifting · 70 from the failing basin, 19 from restoration.
Good elements to keep
- Protein (supports)perturbation · steering +13.4
- Butyrate producers intacthidden · steering +7.5
- Daily walks resumedperturbation · steering +3.3
- Proteinsupporter · GI -7.2 next day
Main detractors to watch
- Alcoholperturbation · steering -10.5
- Poor-sleep weekperturbation · steering -3
- Dietary driftperturbation · steering -2.6
- Alcoholdetractor · GI +5.9 next day
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-7.2supporter · 95%
- Alcohol+5.9detractor · 95%
- Simple carbohydrates+1.3no signal · 27%
- Insoluble fibre+1.3no signal · 26%
- Caffeine-0.9no signal · 16%
- Histamine load-0.5no signal · 15%
- Dietary fat load+0.1no signal · 15%
- Ultra-processed food0no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
- Inflammatory signalling ↓15
- WearableHRV 35 ms, trending down
DNA
Fictional pharmacogenomic panel
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 4 · butyrate capacity 61/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumNormal
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 35 ms
- Sleep
- 6.3 h
- Steps
- 7,004
- Resting HR
- 59 bpm
Daily log: GI score 25, nutritional resilience 60, adherence 86.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-02518 | 48% | S17 | DT-01 | improved | 68 |
| P-02462 | 47% | S12 | DT-01 | improved | 65 |
| P-02698 | 45% | S06 | ME-01 | improved | 71 |
| P-02064 | 44% | S04 | SC-12 | improved | 57 |
| P-02354 | 43% | S01 | CR-01 | improved | 78 |
| P-02538 | 43% | S02 | GI-04 | improved | 59 |
| P-02599 | 42% | S14 | HY-01 | improved | 54 |
| P-02037 | 41% | S04 | GI-04 | improved | 53 |
| P-02126 | 41% | S16 | DT-01 | improved | 59 |
| P-02235 | 41% | S14 | DT-01 | improved | 50 |
| P-02274 | 41% | S15 | DT-01 | improved | 50 |
| P-02485 | 41% | S05 | HY-01 | improved | 63 |